#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	704	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1205	31.3	0	.	p	.	0	K29T	NONSYN	85	87	AAG	353	355	ACG	48;49;49	A;C;G	48;49;49	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2770	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1458	94.9	1	SNP	p	R234F	1	.	.	700	702	TTC	947	949	TTC	130;133;133	T;T;C	128;133;133	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2770	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1458	94.9	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1247	1249	CGT	123;123;121	C;G;T	123;121;120	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2770	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1458	94.9	0	HET	.	.	.	T999C	.	999	999	T	1246	1246	T	116	T,C	68,46	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2770	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1458	94.9	0	HET	.	.	.	T180C	.	180	180	T	427	427	T	82	T,C	50,27	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2770	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1458	94.9	0	HET	.	.	.	C261T	.	261	261	C	508	508	C	106	C,T	55,48	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2770	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.3	158	15.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1018	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1689	32.3	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1481	1483	AAA	22;21;20	A;A;A	22;21;20	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1484	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1734	46.0	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1245	1247	GAA	53;50;50	G;A;A	53;49;50	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	286	H_NS	414	414	99.03	H_NS.l6.c30.ctg.1	850	18.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	175	G	174	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	157	C	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	139	C	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	211	T	211	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	256	C	256	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	166	C	166	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	159	A	159	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	157	A	156	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	151	A	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	130	T	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	128	C	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	133	C	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	133	A	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	123	G	123	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	128	C	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	140	T	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	190	G,T	186,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	200	G	199	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	199	T	197	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	219	T	219	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	208	G	207	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	160	C	160	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	152	A	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	138	C	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	141	C	141	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	72	A	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	70	A	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	64	G	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	59	C	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	115	T	115	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	126	G	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	98	T	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	734	146.0	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	279	C	276	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	.	n	.	0	C990G	SNP	990	990	C	29	29	G	22	G	21	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	.	n	.	0	T1002A	SNP	1002	1002	T	41	41	A	30	A	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	.	n	.	0	A1003C	SNP	1003	1003	A	42	42	C	30	C	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	.	n	.	0	G1008C	SNP	1008	1008	G	47	47	C	32	C,G	0,32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	.	n	.	0	C1011T	SNP	1011	1011	C	50	50	T	39	T	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	.	n	.	0	C1023A	SNP	1023	1023	C	62	62	A	45	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	.	n	.	0	T1024A	SNP	1024	1024	T	63	63	A	45	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	.	n	.	0	T1041G	SNP	1041	1041	T	80	80	G	49	G	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	.	n	.	0	A1042T	SNP	1042	1042	A	81	81	T	47	T	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4266	Pasteurella_multocida_16S	1551	132	90.15	Pasteurella_multocida_16S.l15.c17.ctg.4	132	28.1	0	HET	.	.	.	A1004G	.	1004	1004	A	43	43	A	30	A,G	0,30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1064	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1565	36.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	275	277	CGT	36;36;35	C;G;T	36;36;35	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1064	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1565	36.6	0	.	p	.	0	V30I	NONSYN	88	90	GTC	359	361	ATC	40;40;40	A;T;C	40;40;40	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1064	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1565	36.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1118	1120	GGC	51;53;52	G;G;C	51;53;52	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1542	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2142	38.8	0	.	p	.	0	R8S	NONSYN	22	24	AGA	287	289	AGC	19;19;19	A;G;C	19;19;19	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1542	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2142	38.8	0	.	p	.	0	I142L	NONSYN	424	426	ATA	689	691	CTA	43;43;42	C;T;A	43;43;42	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1542	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2142	38.8	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1208	1210	CAA	61;62;60	C;A;A	61;62;60	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1542	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2142	38.8	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1307	1309	GGT	51;50;49	G;G;T	51;50;49	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1542	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2142	38.8	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1877	1879	GTT	31;30;31	G;T;T	31;30;31	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	476	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1490	17.2	0	.	p	.	0	A125E	NONSYN	373	375	GCA	547	549	GAA	13;14;13	G;A;A	13;14;13	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	476	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1490	17.2	0	.	p	.	0	M185T	NONSYN	553	555	ATG	727	729	ACC	8;8;9	A;C;C	8;8;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	476	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1490	17.2	0	.	p	.	0	S225T	NONSYN	673	675	TCC	847	849	ACT	13;13;13	A;C;T	13;13;13	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	476	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1490	17.2	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1237	1239	ATC	18;18;18	A;T;C	18;18;18	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	770	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1394	29.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	528	60	acrB	3147	177	90.4	acrB.l6.c4.ctg.2	177	6.4	0	.	p	.	0	N146D	NONSYN	436	438	AAC	166	168	GAT	1;1;1	G;A;T	1;1;1	.	acrB;Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2558	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3532	39.0	0	.	p	.	0	T85I	NONSYN	253	255	ACC	509	511	ATC	40;40;39	A;T;C	40;40;39	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2558	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3532	39.0	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2222	2224	AAG	25;28;28	A;A;G	25;27;28	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1106	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1703	35.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	317	319	GTC	8;7;8	G;T;C	8;7;8	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1106	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1703	35.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1058	1060	TGC	47;46;49	T;G;C	47;46;49	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2502	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3089	43.3	0	.	p	.	0	S46trunc	TRUNC	136	136	T	367	367	T	37	T	37	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2502	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3089	43.3	0	.	p	.	0	G148D	NONSYN	442	444	GGC	673	675	GAC	53;58;58	G;A;C	51;58;57	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2502	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3089	43.3	0	.	p	.	0	F240L	NONSYN	718	720	TTT	949	951	TTA	29;27;26	T;T;A	29;27;25	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2502	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3089	43.3	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1132	1134	AAT	31;31;31	A;A;T	30;30;31	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2502	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3089	43.3	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1919	1919	T	59	T	59	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	508	acrR_2	648	648	99.54	acrR_2.l15.c17.ctg.1	1152	23.7	1	SNP	p	R45C	0	.	.	133	135	CGC	384	386	CGC	39;41;41	C;G;C	38;41;41	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	470	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1031	24.6	0	.	p	.	0	L34F	NONSYN	100	102	CTC	233	235	TTC	28;28;28	T;T;C	27;28;26	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	470	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1031	24.6	0	.	p	.	0	E122G	NONSYN	364	366	GAG	497	499	GGG	43;43;43	G;G;G	42;43;43	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	580	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1102	28.3	0	.	p	.	0	V136L	NONSYN	406	408	GTT	547	549	CTT	56;58;59	C;T;T	56;58;59	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2520	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3098	43.8	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2082	2084	GCA	51;51;54	G;C;A	51;50;54	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2520	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3098	43.8	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2343	2345	ACC	37;35;36	A;C;C	37;35;36	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2520	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3098	43.8	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2652	2654	GCC	44;45;44	G;C;C	44;45;43	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1284	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	29.5	0	.	p	.	0	G37A	NONSYN	109	111	GGT	241	243	GCT	9;9;12	G;C;T	9;9;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1284	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	29.5	0	.	p	.	0	D77E	NONSYN	229	231	GAT	361	363	GAG	18;18;17	G;A;G	18;18;17	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1284	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	29.5	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	397	399	TGC	22;23;24	T;G;C	22;23;24	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1284	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	29.5	0	.	p	.	0	I150V	NONSYN	448	450	ATT	580	582	GTT	24;25;26	G;T;T	24;25;26	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1284	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	29.5	0	.	p	.	0	R200H	NONSYN	598	600	CGC	730	732	CAC	34;35;35	C;A;C	34;35;35	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1284	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	29.5	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1015	1017	ATG	39;39;41	A;T;G	38;39;40	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1284	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	29.5	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2011	2013	CGC	35;36;38	C;G;C	35;36;36	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	528	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1208	23.4	0	.	p	.	0	S221T	NONSYN	661	663	AGC	846	848	ACC	25;24;21	A;C;C	25;24;21	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	528	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1208	23.4	0	.	p	.	0	P225S	NONSYN	673	675	CCG	858	860	TCG	21;21;23	T;C;G	21;21;23	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	492	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1095	24.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	866	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1821	25.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1343	1345	AAA	19;18;18	A;A;A	18;18;18	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	866	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1821	25.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1355	1357	GAG	12;11;11	G;A;G	12;11;11	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	866	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1821	25.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1361	1363	CAC	12;13;13	C;A;C	12;13;13	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	866	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1821	25.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1415	1417	GAG	22;21;21	G;A;G	22;21;21	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1272	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1893	36.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	696	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1206	31.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	746	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1277	31.4	0	.	p	.	0	A146T	NONSYN	436	438	GCT	606	608	ACT	43;42;42	A;C;T	43;42;42	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	414	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	916	24.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	996	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1616	33.1	0	.	p	.	0	I219V	NONSYN	655	657	ATC	872	874	GTC	49;48;48	G;T;C	47;47;47	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1444	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2047	38.0	0	.	p	.	0	E197K	NONSYN	589	591	GAA	853	855	AAA	44;45;45	A;A;A	44;45;45	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1008	emrD	1191	1191	98.4	emrD.l15.c17.ctg.1	1617	33.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	870	872	AGC	32;33;34	A;G;C	32;33;32	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	19	38	emrE_1	333	274	93.43	emrE_1.l15.c30.ctg.1	274	5.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	646	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1550	22.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	747	749	AGG	22;22;22	A;G;G	22;22;22	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	646	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1550	22.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1137	1139	GAC	20;19;19	G;A;C	20;19;19	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	422	emrR	531	531	100.0	emrR.l15.c17.ctg.1	945	24.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	926	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	1990	25.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	392	evgA	615	615	99.19	evgA.l15.c17.ctg.1	1088	19.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	420	422	CTG	25;25;26	C;T;G	25;25;26	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	T38I	NONSYN	112	114	ACA	266	268	ATA	26;26;25	A;T;A	26;26;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	L42V	NONSYN	124	126	CTA	278	280	GTA	22;22;22	G;T;A	22;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	431	433	ACG	19;21;19	A;C;G	19;21;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	494	496	GAA	16;16;16	G;A;A	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	533	535	GCT	10;9;10	G;C;T	10;9;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	551	553	GAT	12;12;12	G;A;T	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	638	640	TCA	14;13;13	T;C;A	14;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	767	769	CAG	11;12;12	C;A;G	11;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	905	907	GTT	14;15;15	G;T;T	14;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1061	1063	GAT	6;6;6	G;A;T	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1229	1231	AAT	7;7;7	A;A;T	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1250	1252	TTA	5;4;4	T;T;A	5;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1451	1453	AAA	16;16;16	A;A;A	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2186	2188	CAT	22;22;22	C;A;T	22;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2240	2242	CAT	24;24;24	C;A;T	24;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2258	2260	AGA	24;22;23	A;G;A	24;22;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2273	2275	AAT	22;22;23	A;A;T	22;22;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2420	2422	TCC	24;24;24	T;C;C	24;23;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2585	2587	ATT	23;22;21	A;T;T	22;22;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2606	2608	GAT	21;24;24	G;A;T	21;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2720	2722	GTT	29;29;28	G;T;T	29;29;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1830	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3914	25.1	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3005	3007	CAC	37;37;35	C;A;C	37;36;35	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	728	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	31.1	1	SNP	p	P64H	0	.	.	190	192	CCA	374	376	CCA	53;51;48	C;C;A	53;50;46	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	728	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	31.1	1	SNP	p	P64L	0	.	.	190	192	CCA	374	376	CCA	53;51;48	C;C;A	53;50;46	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	728	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	31.1	1	SNP	p	P64R	0	.	.	190	192	CCA	374	376	CCA	53;51;48	C;C;A	53;50;46	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	728	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	31.1	1	SNP	p	P64A	0	.	.	190	192	CCA	374	376	CCA	53;51;48	C;C;A	53;50;46	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	728	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	31.1	1	SNP	p	P64S	0	.	.	190	192	CCA	374	376	CCA	53;51;48	C;C;A	53;50;46	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	344	gadE	528	528	100.0	gadE.l15.c4.ctg.1	958	19.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	88	gadW	729	571	94.22	gadW.l6.c4.ctg.1	635	7.4	0	.	p	.	0	E54D	NONSYN	160	162	GAA	2	4	GAT	3;5;5	G;A;T	3;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	88	gadW	729	571	94.22	gadW.l6.c4.ctg.1	635	7.4	0	.	p	.	0	I88M	NONSYN	262	264	ATA	104	106	ATG	4;4;4	A;T;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	88	gadW	729	571	94.22	gadW.l6.c4.ctg.1	635	7.4	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	107	109	CCG	4;5;5	C;C;G	4;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	88	gadW	729	571	94.22	gadW.l6.c4.ctg.1	635	7.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	140	142	GAA	3;3;3	G;A;A	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	88	gadW	729	571	94.22	gadW.l6.c4.ctg.1	635	7.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	143	145	TCC	3;3;3	T;C;C	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	88	gadW	729	571	94.22	gadW.l6.c4.ctg.1	635	7.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	146	148	GGG	3;3;3	G;G;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	88	gadW	729	571	94.22	gadW.l6.c4.ctg.1	635	7.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	170	172	AAT	3;3;3	A;A;T	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	88	gadW	729	571	94.22	gadW.l6.c4.ctg.1	635	7.4	0	.	p	.	0	S234A	NONSYN	700	702	TCG	542	544	GCG	4;4;4	G;C;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	418	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1148	19.6	0	.	p	.	0	F53L	NONSYN	157	159	TTC	322	324	TTA	23;22;22	T;T;A	23;22;22	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	418	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1148	19.6	0	.	p	.	0	V79I	NONSYN	235	237	GTT	400	402	ATT	19;19;17	A;T;T	19;19;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	418	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1148	19.6	0	.	p	.	0	R246G	NONSYN	736	738	AGA	901	903	GGA	9;8;9	G;G;A	9;8;9	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	418	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1148	19.6	0	.	p	.	0	S248P	NONSYN	742	744	TCG	907	909	CCG	8;8;8	C;C;G	8;8;8	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2438	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3135	41.9	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2281	2283	GAA	36;37;38	G;A;A	36;37;38	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2438	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3135	41.9	1	SNP	p	S83W	0	.	.	247	249	TCG	496	498	TCG	53;53;51	T;C;G	52;53;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2438	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3135	41.9	1	SNP	p	S83L	0	.	.	247	249	TCG	496	498	TCG	53;53;51	T;C;G	52;53;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2438	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3135	41.9	1	SNP	p	S83I	0	.	.	247	249	TCG	496	498	TCG	53;53;51	T;C;G	52;53;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2438	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3135	41.9	1	SNP	p	D87Y	0	.	.	259	261	GAC	508	510	GAC	51;49;48	G;A;C	48;48;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2438	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3135	41.9	1	SNP	p	D87H	0	.	.	259	261	GAC	508	510	GAC	51;49;48	G;A;C	48;48;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2438	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3135	41.9	1	SNP	p	D87N	0	.	.	259	261	GAC	508	510	GAC	51;49;48	G;A;C	48;48;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2438	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3135	41.9	1	SNP	p	D87G	0	.	.	259	261	GAC	508	510	GAC	51;49;48	G;A;C	48;48;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2438	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3135	41.9	1	SNP	p	D87V	0	.	.	259	261	GAC	508	510	GAC	51;49;48	G;A;C	48;48;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2256	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2853	42.5	1	SNP	p	R136C	0	.	.	406	408	CGC	622	624	CGC	42;43;43	C;G;C	42;43;43	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2256	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2853	42.5	1	SNP	p	R136H	0	.	.	406	408	CGC	622	624	CGC	42;43;43	C;G;C	42;43;43	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2256	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2853	42.5	1	SNP	p	R136S	0	.	.	406	408	CGC	622	624	CGC	42;43;43	C;G;C	42;43;43	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2256	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2853	42.5	1	SNP	p	R136E	0	.	.	406	408	CGC	622	624	CGC	42;43;43	C;G;C	42;43;43	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2256	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2853	42.5	1	SNP	p	R136G	0	.	.	406	408	CGC	622	624	CGC	42;43;43	C;G;C	42;43;43	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2256	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2853	42.5	1	SNP	p	R136I	0	.	.	406	408	CGC	622	624	CGC	42;43;43	C;G;C	42;43;43	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2256	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2853	42.5	1	SNP	p	R136L	0	.	.	406	408	CGC	622	624	CGC	42;43;43	C;G;C	42;43;43	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	462	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1031	24.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	458	460	CCG	32;33;34	C;C;G	32;33;34	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	462	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1031	24.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	611	613	GCC	23;23;22	G;C;C	23;23;22	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	808	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1250	34.7	0	.	p	.	0	P9S	NONSYN	25	27	CCA	209	211	TCA	21;19;19	T;C;A	21;18;19	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	234	marA	384	384	99.74	marA.l6.c30.ctg.1	845	14.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	543	545	AGC	13;12;13	A;G;C	13;12;13	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	645	647	CAT	3;3;3	C;A;T	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	V45E	0	.	.	133	135	GTG	369	371	GTG	39;36;36	G;T;G	38;36;35	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	I49S	0	.	.	145	147	ATC	381	383	ATC	32;31;30	A;T;C	32;31;30	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	A70T	0	.	.	208	210	GCA	444	446	GCA	26;26;26	G;C;A	26;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	R73C	0	.	.	217	219	CGT	453	455	CGT	25;25;23	C;G;T	25;24;23	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	R73S	0	.	.	217	219	CGT	453	455	CGT	25;25;23	C;G;T	25;24;23	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	R77L	0	.	.	229	231	CGC	465	467	CGC	25;24;24	C;G;C	25;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	R77C	0	.	.	229	231	CGC	465	467	CGC	25;24;24	C;G;C	25;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	L78M	0	.	.	232	234	CTG	468	470	CTG	24;24;23	C;T;G	24;24;23	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	R94S	0	.	.	280	282	CGC	516	518	CGC	20;20;19	C;G;C	20;20;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	R94H	0	.	.	280	282	CGC	516	518	CGC	20;20;19	C;G;C	20;20;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l15.c30.ctg.1	744	15.7	1	SNP	p	V96E	0	.	.	286	288	GTA	522	524	GTA	19;19;19	G;T;A	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	S7F	NONSYN	19	21	TCC	20	22	TTC	3;3;3	T;T;C	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	R36I	NONSYN	106	108	AGG	107	109	ATC	10;11;11	A;T;C	10;11;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	E42A	NONSYN	124	126	GAA	125	127	GCC	6;6;6	G;C;C	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	N43V	NONSYN	127	129	AAT	128	130	GTG	7;7;7	G;T;G	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	E52D	NONSYN	154	156	GAG	155	157	GAT	12;12;12	G;A;T	12;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	N59T	NONSYN	175	177	AAC	176	178	ACC	12;12;12	A;C;C	12;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	I68L	NONSYN	202	204	ATA	203	205	TTA	17;16;15	T;T;A	17;16;15	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	344	346	CAG	32;32;31	C;A;G	32;32;31	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	383	385	GCC	26;26;27	G;C;C	26;26;27	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	488	490	GCG	25;25;24	G;C;G	25;24;24	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	L231V	NONSYN	691	693	CTT	692	694	GTT	23;23;24	G;T;T	19;21;22	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	616	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1334	24.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	854	854	C	28	C	28	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	656	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1754	20.2	0	.	p	.	0	V12trunc	TRUNC	34	34	G	259	259	G	28	G	28	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	656	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1754	20.2	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	316	318	CAG	14;14;15	C;A;G	14;14;15	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	656	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1754	20.2	0	.	p	.	0	T83I	NONSYN	247	249	ACC	466	468	ATC	21;20;20	A;T;C	21;20;20	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	656	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1754	20.2	0	.	p	.	0	I99M	NONSYN	295	297	ATA	514	516	ATG	19;19;19	A;T;G	19;19;19	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	656	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1754	20.2	0	.	p	.	0	A130T	NONSYN	388	390	GCC	607	609	ACC	17;18;18	A;C;C	17;18;18	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	656	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1754	20.2	0	.	p	.	0	P257T	NONSYN	769	771	CCG	988	990	ACG	24;24;22	A;C;G	24;24;22	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2544	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3559	38.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1990	1992	ACC	43;42;42	A;C;C	43;42;42	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2544	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3559	38.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2383	2385	CAA	31;29;28	C;A;A	30;28;26	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2544	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3559	38.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2551	2553	ATT	24;25;25	A;T;T	24;25;25	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2544	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3559	38.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2635	2637	GTT	26;26;25	G;T;T	26;26;25	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2544	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3559	38.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2743	2745	GAG	28;28;29	G;A;G	28;26;28	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2544	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3559	38.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2971	2973	ATG	41;40;39	A;T,A;G	41;39,1;39	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2544	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3559	38.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3106	3108	GAT	30;30;32	G;A;T	30;29;32	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2342	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3523	35.8	0	.	p	.	0	I46M	NONSYN	136	138	ATC	304	306	ATG	21;21;21	A;T;G	20;21;21	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2342	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3523	35.8	0	.	p	.	0	V208I	NONSYN	622	624	GTC	790	792	ATC	43;46;47	A;T;C	43;46;46	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2342	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3523	35.8	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3106	3108	CAC	8;9;9	C;A;C	8;9;9	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2342	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3523	35.8	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3109	3111	CTC	9;11;10	C;T;C	9;10;10	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1154	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1891	32.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	252	254	GAA	16;15;15	G;A;A	16;15;15	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1154	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1891	32.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	921	923	GCG	48;51;51	G;C;G	46;49;50	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1154	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1891	32.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1263	1265	ATC	38;37;38	A;T;C	37;37;38	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1154	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1891	32.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1566	1568	TTT	39;39;38	T;T;T	39;39;38	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1230	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1662	39.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2798	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3437	43.7	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1041	1043	ACC	41;41;40	A;C,A;C	40;38,1;40	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2798	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3437	43.7	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2283	2285	GAC	42;41;44	G;A;C	42;40;44	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	876	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.1	1556	24.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	654	656	ATC	23;24;26	A;T;C	23;24;26	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	876	mdtG	1227	182	99.45	mdtG.l15.c17.ctg.2	586	14.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	173	175	GGA	13;15;16	G;G;A	13;15;16	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	868	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1556	30.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	570	572	TGT	40;40;42	T;G;T	40;40;42	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	868	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1556	30.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1140	1142	TTG	33;32;32	T;T;G	33;32;32	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	868	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1556	30.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1350	1352	ACG	11;13;13	A;C;G	11;13;13	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1102	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1746	33.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	864	866	TCC	26;26;24	T;C;C	23;25;24	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	806	mdtN	1032	1032	98.02	mdtN.l15.c30.ctg.1	1480	29.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	552	554	ATT	30;31;34	A;T;T	30;31;34	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	V11M	NONSYN	31	33	GTG	215	217	ATG	17;17;17	A;T;G	17;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	T33I	NONSYN	97	99	ACC	281	283	ATC	23;25;27	A;T;C	22;24;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	C116R	NONSYN	346	348	TGC	530	532	CGC	40;40;40	C;G;C	39;38;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	N238S	NONSYN	712	714	AAC	896	898	AGC	35;34;33	A;G;C	35;33;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1097	1099	GTG	28;28;27	G;T;G	28;26;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1160	1162	AAC	18;17;18	A;A;C	17;15;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1205	1207	GTC	29;29;28	G;T;C	29;29;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1235	1237	ATA	38;37;37	A;T;A	38;36;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1343	1345	TCT	34;32;33	T;C;T	34;32;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1730	1732	GCG	50;49;51	G;C;G	48;48;50	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2433	39.2	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1943	1945	ATC	45;47;47	A;T,G;C	45;46,1;47	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1719	34.7	0	.	p	.	0	S129A	NONSYN	385	387	TCA	636	638	GCG	42;44;45	G;C;G	41;43;44	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1719	34.7	0	.	p	.	0	A187T	NONSYN	559	561	GCC	810	812	ACC	44;45;47	A;C;C	42;45;47	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1719	34.7	0	.	p	.	0	H211R	NONSYN	631	633	CAC	882	884	CGC	40;39;40	C;G;C	40;39;40	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1719	34.7	0	.	p	.	0	V250A	NONSYN	748	750	GTT	999	1001	GCT	37;37;36	G;C;T	37;37;35	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1719	34.7	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1083	1085	AAA	30;29;30	A;A;A	30;29;30	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1719	34.7	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1101	1103	CGA	30;32;33	C;G;A	29;32;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1719	34.7	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1266	1268	GCC	23;23;22	G;C;C	23;23;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1719	34.7	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1278	1280	GAT	25;23;23	G;A;T	25;23;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1719	34.7	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1695	1697	GCT	11;9;8	G;C;T	11;9;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2820	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	3934	38.6	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1577	1579	AAG	32;31;31	A;A;G	32;31;31	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2820	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	3934	38.6	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2654	2656	CTG	30;31;32	C;T;G	30;31;32	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	192	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	630	16.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1480	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2149	37.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1036	1038	AAC	29;29;29	A;A;C	29;29;29	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1480	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2149	37.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1582	1584	ATA	44;45;44	A;T;A	44;45;44	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1356	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1656	44.1	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1318	1320	GAT	51;51;52	G;A;T	51;51;52	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1356	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1656	44.1	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1321	1323	CTG	51;52;50	C;T;G	51;52;49	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	606	nfsA	723	379	98.94	nfsA.l6.c4.ctg.1	850	23.8	0	.	p	.	0	R27C	NONSYN	79	81	CGT	320	322	TGT	25;23;24	T;G;T	25;23;24	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	606	nfsA	723	379	98.94	nfsA.l6.c4.ctg.1	850	23.8	0	.	p	.	0	I117T	NONSYN	349	351	ATC	590	592	ACC	42;41;40	A;C;C	42;41;40	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	606	nfsA	723	379	98.94	nfsA.l6.c4.ctg.1	850	23.8	1	SNP	p	R15C	0	.	.	43	45	CGC	284	286	CGC	43;42;40	C;G;C	43;41;40	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	606	nfsA	723	379	98.94	nfsA.l6.c4.ctg.1	850	23.8	1	SNP	p	S33R	0	.	.	97	99	AGC	338	340	AGC	26;26;26	A;G;C	26;26;26	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	606	nfsA	723	353	99.15	nfsA.l6.c4.ctg.2	674	17.8	0	.	p	.	0	G187D	NONSYN	559	561	GGC	362	364	GAC	29;29;30	G;A;C	29;29;30	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	606	nfsA	723	353	99.15	nfsA.l6.c4.ctg.2	674	17.8	1	SNP	p	G131D	0	.	.	391	393	GGC	194	196	GGC	29;30;30	G;G;C	29;30;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	606	nfsA	723	353	99.15	nfsA.l6.c4.ctg.2	674	17.8	1	SNP	p	R203C	0	.	.	607	609	CGT	410	412	CGT	30;29;29	C;G;T	30;29;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	606	nfsA	723	353	99.15	nfsA.l6.c4.ctg.2	674	17.8	1	SNP	p	R203L	0	.	.	607	609	CGT	410	412	CGT	30;29;29	C;G;T	30;29;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1052	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	35.8	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1167	1169	GAG	54;55;55	G;A;G	53;54;53	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1052	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	35.8	1	SNP	p	G141E	0	.	.	421	423	GGT	654	656	GGT	55;54;52	G;G;T	54;53;52	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1052	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	35.8	1	SNP	p	G141D	0	.	.	421	423	GGT	654	656	GGT	55;54;52	G;G;T	54;53;52	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1052	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	35.8	1	SNP	p	R154D	0	.	.	460	462	CGT	693	695	CGT	52;52;52	C;G;T	51;52;52	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1052	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	35.8	1	SNP	p	R154A	0	.	.	460	462	CGT	693	695	CGT	52;52;52	C;G;T	51;52;52	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2184	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2729	43.0	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1844	1846	GTG	46;46;45	G;T;G	45;46;45	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2184	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2729	43.0	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1871	1873	TCG	47;46;47	T;C;G	45;44;47	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2184	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2729	43.0	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2486	2488	AAC	26;26;26	A;A;C	26;26;25	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2184	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2729	43.0	1	SNP	p	A85T	0	.	.	253	255	GCG	500	502	GCG	48;48;50	G;C;G	47;47;50	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2184	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2729	43.0	1	SNP	p	D111H	0	.	.	331	333	GAT	578	580	GAT	42;43;42	G;A,G;T	42;42,1;42	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2184	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2729	43.0	1	SNP	p	S129P	0	.	.	385	387	TCC	632	634	TCC	54;58;58	T;C;C	49;57;56	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1392	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2434	30.9	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1647	1649	AAC	32;33;34	A;A;C	32;33;34	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1392	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2434	30.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1656	1658	GAT	41;42;41	G;A;T	40;42;41	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1364	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1979	37.2	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	881	883	CAG	53;52;53	C;A;G	53;52;53	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1364	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1979	37.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1355	1357	GAT	57;59;59	G;A;T	57;59;59	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	V146F	0	.	.	436	438	GTT	711	713	GTT	53;52;51	G;T;T	53;52;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1812	1814	CAG	51;55;55	C;A;G	51;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1812	1814	CAG	51;55;55	C;A;G	51;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1851	1853	CAC	50;49;47	C,G;A;C	49,1;49;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1860	1862	CGT	48;47;46	C;G;T	48;47;45	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1860	1862	CGT	48;47;46	C;G;T	48;47;45	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1866	1868	TCC	46;42;42	T;C;C	45;42;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1872	1874	CTC	42;41;41	C;T;C	42;41;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1962	1964	ACC	49;49;50	A;C;C	49;49;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1965	1967	CCT	51;51;52	C;C;T	51;51;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4388	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4500	52.5	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2334	2336	CGT	80;82;80	C;G;T	80;82;80	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	.	n	.	0	A226G	SNP	226	226	A	351	351	G	401	G	401	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	1	SNP	n	A794G	0	.	.	794	794	A	919	919	A	340	A	332	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	1	SNP	n	A794T	0	.	.	794	794	A	919	919	A	340	A	332	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	1	SNP	n	G926A	0	.	.	926	926	G	1051	1051	G	305	G	303	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	1	SNP	n	G926C	0	.	.	926	926	G	1051	1051	G	305	G	303	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	1	SNP	n	G926T	0	.	.	926	926	G	1051	1051	G	305	G	303	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	HET	.	.	.	A79G	.	79	79	A	204	204	A	295	A,G	217,76	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	HET	.	.	.	C719T	.	719	719	C	844	844	C	335	C,T	242,92	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	HET	.	.	.	T273A	.	273	273	T	398	398	T	356	T,A	259,90	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	HET	.	.	.	C183T	.	183	183	C	308	308	C	358	C,T	231,125	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	HET	.	.	.	A250T	.	250	250	A	375	375	A	355	A,T	274,81	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	HET	.	.	.	T90C	.	90	90	T	215	215	T	306	T,C	216,87	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	HET	.	.	.	G474A	.	474	474	G	599	599	G	348	G,A	267,77	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	HET	.	.	.	A253T	.	253	253	A	378	378	A	356	A,T	271,82	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	999	99.9	rrsB+.l15.c30.ctg.1	1124	319.1	0	HET	.	.	.	C194T	.	194	194	C	319	319	C	369	C,T	291,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	501	100.0	rrsB+.l15.c30.ctg.2	661	325.8	1	SNP	n	A1519C	0	.	.	1519	1519	A	478	478	A	315	A	313	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	501	100.0	rrsB+.l15.c30.ctg.2	661	325.8	1	SNP	n	A1519G	0	.	.	1519	1519	A	478	478	A	315	A	313	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	501	100.0	rrsB+.l15.c30.ctg.2	661	325.8	1	SNP	n	A1519T	0	.	.	1519	1519	A	478	478	A	315	A	313	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	115.3	0	.	n	.	0	G1002A	SNP	1002	1002	G	53	53	A	168	A,C	166,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	115.3	0	.	n	.	0	G1006C	SNP	1006	1006	G	57	57	C	175	C	173	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	115.3	0	.	n	.	0	T1010C	SNP	1010	1010	T	61	61	C	175	C	173	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	115.3	0	.	n	.	0	A1019.	DEL	1019	1019	A	69	69	G	168	G	166	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	115.3	0	.	n	.	0	.1023G	INS	1023	1023	T	74	74	G	161	G	161	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	115.3	0	.	n	.	0	C1038T	SNP	1038	1038	C	89	89	T	153	T,C	149,4	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11456	rrsB+	1542	135	100.0	rrsB+.l15.c30.ctg.4	135	59.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	694	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	969	38.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	480	soxR	465	465	100.0	soxR.l6.c30.ctg.1	894	28.7	1	SNP	p	R20H	0	.	.	58	60	CGC	281	283	CGC	33;34;34	C;G;C	33;34;34	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	480	soxR	465	465	100.0	soxR.l6.c30.ctg.1	894	28.7	1	SNP	p	G121D	0	.	.	361	363	GGT	584	586	GGT	58;57;55	G;G;T	58;57;55	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	358	soxS_1	324	324	99.69	soxS_1.l6.c4.ctg.1	866	22.2	1	SNP	p	A12S	0	.	.	34	36	GCA	315	317	GCA	44;43;43	G;C;A	44;43;42	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1324	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1908	37.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
